Please login to the form below

Not currently logged in
Email:
Password:

prescription drugs

This page shows the latest prescription drugs news and features for those working in and with pharma, biotech and healthcare.

Malthus’ orphans

Malthus’ orphans

Malthus came to mind this week as I read a valuable report from EvaluatePharma, which predicts that orphan drugs will capture no less than 20% of spend on prescription drugs by ... By and large, rare diseases and orphan drugs don’t lend themselves to

Latest news

  • Trump attempts The Art of the Deal with pharma Trump attempts The Art of the Deal with pharma

    The plan seeks to increase competition, improve negotiation and create incentives to lower list prices of prescription drugs and out-of-pocket costs for consumers. ... controls and therefore pay less for drugs than Americans, while US companies invest in

  • Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report

    Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report. ... That assertion ties in with its new report on worldwide prescription drug sales, which says that drugs for orphan diseases will outperform the overall pharma market,

  • Novartis plans digital therapeutics for schizophrenia and MS Novartis plans digital therapeutics for schizophrenia and MS

    Novartis plans digital therapeutics for schizophrenia and MS. Will work with Pear Therapeutics on a prescription software range. ... Novartis shares our vision for prescription digital therapeutics that work alongside drugs to deliver superior patient

  • Not in my backyard Not in my backyard

    Not in my backyard. Let’s be honest: the notion that you can import prescription drugs from one country at a cheaper price and pass those savings on to consumers in ... And if 40% of US prescriptions flow through Canada, the branded prescription drug

  • Millennials’ disappointing medicine habits Millennials’ disappointing medicine habits

    The UK has an ‘under-informed’youth when it comes to prescription medicines, according to a new patient behaviour survey from the IPA’s Healthcare Group.

More from news
Approximately 2 fully matching, plus 174 partially matching documents found.

Latest Intelligence

  • US health reforms US health reforms

    In a very real way, the cost of drugs in US - the only developed nation without some form of cost control - can affect the global marketplace. ... Several studies have shown that the United States spends considerably more per capita on prescription drugs

  • Re-awakening the emotion in healthcare communications Re-awakening the emotion in healthcare communications

    phrases. For healthcare companies, it was the same. However, it started to change when the ABPI established the Prescription Medicines Code of Practice Authority (PMCPA) in 1993 to operate the Code ... At the time, they knew the campaign would test the

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    The accompanying figure summarises the measures that target spending on prescription drugs. ... Governments have typically begun by exploring opportunities to negotiate lower prices for orphan drugs.

  • Deal Watch September 2016 Deal Watch September 2016

    India's Sun Pharmaceutical has partnered with Mitsubishi Tanabe Pharma to distribute and market 14 prescription drugs in Japan that Sun recently acquired from Novartis. ... 500. GSK / Aspen. Asset acquisition. Sale of anaesthetic drugs [Ultiva, Nimbex,

  • Market access improvements in Turkey Market access improvements in Turkey

    Almost the entire pharmaceutical market is made up of prescription medicines (93.8%) with 87% reimbursed. ... While welcoming the promise of a slight acceleration of review time with high priority medicines, industry is disappointed that orphan drugs and

More from intelligence
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics